zosuquidar trihydrochloride has been researched along with fluvoxamine in 1 studies
Studies (zosuquidar trihydrochloride) | Trials (zosuquidar trihydrochloride) | Recent Studies (post-2010) (zosuquidar trihydrochloride) | Studies (fluvoxamine) | Trials (fluvoxamine) | Recent Studies (post-2010) (fluvoxamine) |
---|---|---|---|---|---|
6 | 0 | 1 | 2,051 | 518 | 434 |
Protein | Taxonomy | zosuquidar trihydrochloride (IC50) | fluvoxamine (IC50) |
---|---|---|---|
D | Rattus norvegicus (Norway rat) | 0.54 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0038 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.54 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1 | |
Transporter | Rattus norvegicus (Norway rat) | 0.54 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J | 1 |
1 other study(ies) available for zosuquidar trihydrochloride and fluvoxamine
Article | Year |
---|---|
Inhibition of P-glycoprotein by newer antidepressants.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection | 2003 |